Abstract
Background
Hepatic involvement is frequent in patients with cystic fibrosis (CF), with focal biliary cirrhosis being the pathognomonic hepatic manifestation. In around one-quarter of CF patients, it results in CF-associated liver disease (CFLD). This occurs as a relatively early complication with the majority of patients presenting in childhood or their early teens. However, a normal US does not preclude significant liver fibrosis and liver biopsy is an invasive procedure that is hampered by potential sampling errors. Transient elastography (TE) (Fibroscan) is a non-invasive, user-friendly and quick technique that provides an objective and reproducible measure of liver stiffness. This is accomplished with a device using an US probe mounted in the axis of a vibrator. Vibrations are transmitted by the transducer, inducing an electronic shear wave that propagates through the underlying tissue.
Objectives
We aimed to prospectively compare TE and transabdominal US scanning in children and adults attending a CF clinic.
Materials and methods
A total of 134 consecutive patients with documented CF were prospectively studied. In each case, transient elastography measurement was performed immediately after the routine annual US evaluation of the liver. Sonographic appearance of the liver was classified from 1 to 5. Ten validated TE measurements were performed in each patient with the result expressed in kilopascals (kPa). The median value was considered representative of the elastic modulus of the liver.
Results
Measurements were performed in 59 CF adults, 75 CF children and 31 control children. There was no relationship between age and liver stiffness in either the control group or CF patients. Elasticity values of controls, CF pancreatic sufficient (PS) patients and pancreatic insufficient (PI) CF patients with a US score <3 were comparable and significantly lower than in CF patients with a US score ≥ 3 (all PI) (P < 0.002). Median elasticity in CF patients was significantly higher in males (4.7 kPa) than in females (3.9 kPa) (P = 0.0013).
Conclusion
Considering the limitations of US and the low risk-benefit rate of liver biopsy in most CF patients, this preliminary study suggests that TE is an attractive non-invasive way to assess and follow-up liver disease in these patients.
Similar content being viewed by others
References
Stewart L (2005) The role of abdominal ultrasound in the diagnosis, staging and management of cystic fibrosis liver disease. J R Soc Med 98(Suppl 45):17–27
Colombo C, Russo MC, Zazzeron L et al (2006) Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr 43(Suppl 1):S49–55
Dondos V, Westaby D (2007) Liver, biliary and pancreatic disease. In: Hodson M, Geddes D, Bush A (eds) Cystic fibrosis. Hodder Arnold, London, pp 225–240
Lindblad A, Glaumann H, Strandvik B (1999) Natural history of liver disease in cystic fibrosis. Hepatology 30:1151–1158
Colombo C, Battezzati PM, Crosignani A et al (2002) Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome. Hepatology 36:1374–1382
Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500
Ling SC, Wilkinson JD, Hollman AS et al (1999) The evolution of liver disease in cystic fibrosis. Arch Dis Child 81:129–132
Lenaerts C, Lapierre C, Patriquin H et al (2003) Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors. J Pediatr 143:343–350
Mueller-Abt PR, Frawley KJ, Greer RM et al (2007) Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease. J Cyst Fibros 7:215–221
Sandrin L, Fourquet B, Hasquenoph JM et al (2003) Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705–1713
Cobbold JF JFL, Morin S, Taylor-Robinson D (2007) Transient elastography for the assessment of chronic liver disease: Ready for the clinic? World J Gastroenterol 13:4791–4797
Castera L, Forns X, Alberti A (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48:835–847
Yeshua H, Oren R (2008) Non-invasive assessment of liver fibrosis. Ann Transplant 13:5–11
Rockey DC (2008) Non-invasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 134:8–14
Fraquelli M, Rigamonti C, Casazza G et al (2007) Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56:968–973
Corpechot C, El Naggar A, Poujol-Robert A et al (2006) Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43:1118–1124
Gómez-Dominguez E, Mendoza J, García-Buey L et al (2008) Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther 27:441–447
Castéra L, Vergniol J, Foucher J et al (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350
Ziol M, Handra-Luca A, Kettaneh A et al (2005) Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54
Ganne-Carrié N, Ziol M, de Ledinghen V et al (2006) Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 44:1511–1517
Foucher J, Chanteloup E, Vergniol J et al (2006) Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55:403–408
Lupşor M, Badea R, Stefănescu H et al (2008) Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients. J Gastrointestin Liver Dis 17:155–163
Rigamonti C, Donato MF, Fraquelli M et al (2008) Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Gut 57:821–827
Arena U, Vizzutti F, Abraldes GJ et al (2008) Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 57:1288–1293
de Lédinghen V, Le Bail B, Rebouissoux L et al (2007) Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 45:443–450
Nobili V, Vizzutti F, Arena U et al (2008) Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48:442–448
Lucidarme D, Foucher J, Le Bail B et al (2007) The ratio interquartile range/median value of liver stiffness measurements is a key factor of accuracy of transient elastography (FibroScan) for the diagnosis of liver fibrosis (abstract). Hepatology 46:318A
Colombo C, Apostolo MG, Ferrari M et al (1994) Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr 124:393–396
Wilschanski M, Rivlin J, Cohen S et al (1999) Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics 103:52–57
Scott-Jupp R, Lama M, Tanner MS (1991) Prevalence of liver disease in cystic fibrosis. Arch Dis Child 66:698–701
Feigelson J, Anagnostopoulos C, Poquet M et al (1993) Liver cirrhosis in cystic fibrosis. Therapeutic implications and long-term follow-up. Arch Dis Child 68:653–657
Debray D, Lykavieris P, Gauthier F et al (1999) Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension. J Hepatol 31:77–83
Roulot D, Czernichow S, Le Clesiau H et al (2008) Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome. J Hepatol 48:606–613
Colombo C, Apostolo MG, Ferrari M et al (1994) Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr 124:393–399
Fuchs JR, Langer JC (1998) Long-term outcome after neonatal meconium obstruction. Pediatrics 101:E7
Potter CJ, Fishbein M, Hammond S et al (1997) Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria? J Pediatr Gastroenterol Nutr 25:32–36
Coco B, Oliveri F, Maina AM et al (2007) Transient elastography:a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14:360–369
Arena U, Vizzutti F, Corti G et al (2008) Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47:380–384
Sagir A, Erhardt A, Schmitt M et al (2007) Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47:592–595
Talwalkar JA, Kurtz DM, Schoenleber SJ et al (2007) Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 5:1214–1220
Friedrich-Rust M, Ong MF, Martens S et al (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134:960–974
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Menten, R., Leonard, A., Clapuyt, P. et al. Transient elastography in patients with cystic fibrosis. Pediatr Radiol 40, 1231–1235 (2010). https://doi.org/10.1007/s00247-009-1531-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-009-1531-z